Texfer - FCM
- Oncology Therapy
- Nephrology Therapy
- General Medicine
Texfer - FCM
Introduction to FCM
- Ferric Carboxymaltose (FCM) is an injectable iron complex used primarily for treating iron-deficiency anemia (IDA).
- It features a ferric hydroxide core stabilized by a carbohydrate shell, allowing controlled iron delivery to tissues.
- Efficacy
- FCM is highly effective in rapidly replenishing iron stores and increasing hemoglobin levels, especially in patients where oral iron treatments are ineffective or not tolerated.
- Studies from India confirm FCM’s efficiency in correcting moderate-to-severe anemia within a short span (around 4 weeks
- Applications
- Oncology: Effective in cancer patients with iron-deficiency anemia, particularly during chemotherapy.
- Chronic Kidney Disease (CKD): Used in non-dialysis-dependent CKD patients.
- Postpartum: Beneficial for treating anemia in postpartum women, with improved iron stores and minimal side effects.
- Dosage & Composition
- Each ml of the injection contains 50mg of elemental iron, with the product available in 10ml vials (500mg total).
- Safety & Storage:
- The product should be stored in its original packaging at temperatures not exceeding 30°C. Avoid refrigeration or freezing.
- Conclusion
- FCM is a safe, efficient, and rapid treatment option for iron-deficiency anemia across various patient populations